• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Cerulean Pharma Inc

+ Add to Watchlist

CERU:US

3.6100 USD 0.3000 7.67%

As of 20:10:00 ET on 09/22/2014.

Snapshot for Cerulean Pharma Inc (CERU)

Open: 3.9500 Day's Range: 3.6100 - 4.0000 Volume: 55,945
Previous Close: 3.9100 52wk Range: 3.3500 - 8.0600 1-Yr Rtn: -

Stock Chart for CERU

No chart data available.
  • CERU:US 3.6100
  • 1D
  • 1M
  • 1Y
3.9100
Interactive CERU Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CERU

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -1.9050
Est. PEG Ratio -
Market Cap (M USD) 72.65
Shares Outstanding (M) 20.12
30 Day Average Volume 65,142
Price/Book (mrq) 1.2566
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CERU

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CERU

Cerulean Pharma, Inc. designs and develops pharmaceutical products. The Company manufactures therapeutics in the areas of oncology, cardiovascular, autoimmune, and inflammatory diseases as well as tumor cells. Cerulean Pharma operates in the United States.

Oliver S FetzerPresident/CEOEdward GarmeySenior VP/Chief Medical Ofcr
Christopher Damien T Guiffre "Chris"Senior VP/Chief Business OfcrJean SilveriSenior VP/General Counsel
More Company Profile & Key Executives for CERU

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil